Amneal Pharmaceuticals Inc (AMRX) |
|
4.27 0.07 (1.67%)
|
08-13 16:00 |
|
Open: |
4.15 |
Pre. Close: |
4.2 |
|
High:
|
4.305 |
Low:
|
4.101 |
|
Volume:
|
912,440 |
Market Cap:
|
1,280M |
|
|
|
|
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in two segments, Generics and Specialty. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, manufacture, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.31 - 4.339 |
4.339 - 4.364 |
|
Low:
|
4.031 - 4.067 |
4.067 - 4.099 |
|
Close:
|
4.214 - 4.271 |
4.271 - 4.323 |
|
Technical analysis |
as of: 2020-08-13 4:31:32 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 5.75 One year: 6.38 |
| Support: |
Support1: 4.05 Support2: 3.37 |
| Resistance: |
Resistance1: 4.92 Resistance2: 5.46 |
| Pivot: |
4.44  |
| Moving Average: |
MA(5): 4.29 MA(20): 4.48
MA(100): 4.20 MA(250): 3.90 |
| MACD: |
MACD(12,26): -0.07 Signal(9): -0.04 |
| Stochastic oscillator: |
%K(14,3): 12.77 %D(3): 16.00 |
| RSI: |
RSI(14): 45.05 |
| 52-week: |
High: 5.79 Low: 2.27 Change(%): 76.4 |
| Average Vol(K): |
3-Month: 146613 10-Days: 158209 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.AMRX has closed above bottom band by 35.1%. Bollinger Bands are 6.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Thu, 13 Aug 2020
Amneal Pharmaceuticals, Inc. (AMRX) most recent report reveals some hints about its future - The News Heater
Sun, 09 Aug 2020
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha
Thu, 06 Aug 2020
Amneal Pharmaceuticals, Inc. (AMRX) Q2 2020 Earnings Call Transcript - Motley Fool
Thu, 06 Aug 2020
Amneal Pharmaceuticals (AMRX) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Mon, 03 Aug 2020
Amneal (AMRX) to Report Q2 Earnings: What's in the Cards? - Yahoo Finance
Thu, 30 Jul 2020
Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Drug Manufacturers Specialty & Generic |
| Shares Out. (M) |
147 |
| Shares Float (M) |
94 |
|
% Held by Insiders
|
10.36 |
|
% Held by Institutions
|
69.44 |
|
Shares Short (K)
|
7,390 |
|
Shares Short P. Month (K)
|
6,090 |
Stock Financials |
|
EPS
|
-1.455 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
2.160 |
|
Profit Margin
|
-11.85 |
|
Operating Margin
|
5.64 |
|
Return on Assets (ttm)
|
1.4 |
|
Return on Equity (ttm)
|
-58.8 |
|
Qtrly Rev. Growth
|
11.7 |
|
Gross Profit (p.s.)
|
3.373 |
|
Sales Per Share
|
11.405 |
|
EBITDA (p.s.)
|
2.112 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
159 |
|
Levered Free Cash Flow (M)
|
6 |
Stock Valuations |
|
PE Ratio
|
-2.93 |
|
PEG Ratio
|
|
|
Price to Book value
|
1.98 |
|
Price to Sales
|
0.37 |
|
Price to Cash Flow
|
3.95 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
